GC Asia
-
Pharming Group reopens EMEA’s CB market
Europe’s primary equity-linked market has reopened, with a new €125m convertible bond from Pharming Group, the Dutch speciality pharmaceuticals company.
14 Jan 2020 -
Sinopharm seeks second loan in six months
Sinopharm Holding (China) Finance Leasing Co is seeking a $215m-equivalent loan.
14 Jan 2020 -
Vetter first off the blocks in Schuldschein market
German pharmaceutical firm Vetter launched a Schuldschein on Tuesday, which is the first such offering in the market in 2020.
08 Jan 2020 -
MicroPort plans to spin off CardioFlow unit
Hong Kong-listed MicroPort Scientific Corp is looking at spinning off and listing its heart treatment subsidiary, according to a stock exchange filing.
06 Jan 2020 -
Chinese biotech firm I-Mab launches $111m US listing
I-Mab, a China-based biopharmaceutical company, has kicked off the roadshow for its up to $111.1m Nasdaq IPO, more than two months after filing draft documents with the US regulator.
06 Jan 2020 -
CS hires Deutsche’s von Schwedler for healthcare
Credit Suisse has chosen a banker from Deutsche Bank to co-lead its healthcare team in Europe, the Middle East and Africa.
13 Nov 2019
